FeesSafety
Pluang+

0G launches wrapped tokens on Ethereum, Solana, Base, and Robinhood Chain for cross-chain AI asset use

Protocol Fundamentals
21 Sep 2026, 10:01 WIB
Crypto Briefing
View Source
Bullish
0G launches wrapped tokens on Ethereum, Solana, Base, and Robinhood Chain for cross-chain AI asset use

0G, an AI-focused Layer-1 blockchain, has expanded its wrapped token (W0G) to Ethereum, Solana, Base, and Robinhood Chain, enabling cross-chain trading, bridging, and staking of its native token. This move leverages Chainlink's CCIP for interoperability and includes Robinhood Chain, a new hub for tokenized real-world assets, highlighting 0G's strategy to broaden its ecosystem reach. Additionally, 0G introduced ComFi, a finance layer for AI computation resources, and Ascend, a liquid staking product, further enhancing its modular blockchain infrastructure designed for decentralized AI workloads.

0G's expansion of its wrapped token to multiple blockchains is notable alongside a strong market breadth on Pluang, where 41 of 50 major cryptocurrencies rose today. For readers following the broader crypto market, here is Pluang's snapshot as of Sep 21, 2026 13:31 WIB: EGLD (MultiversX) gained 14.14% to Rp75.469 with a typical hold time of 84 days and 77% buy order activity; BAL (Balancer) rose 11.14% to Rp16.297 with an 85-day hold time; and GRT (The Graph) increased 9.24% to Rp402 despite 83% sell order activity and a 98-day hold time.

More News

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

Market News
Bullish
4 hours ago
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Market News
Bullish
4 hours ago
Colin Kaepernick named Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards.

Colin Kaepernick named Humanitarian of the Year at 2026 Muhammad Ali Humanitarian Awards.

At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...

Others
Neutral
5 hours ago
New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.

New Phase 1/2 data show Cabaletta's rese-cel therapy offers durable, immunomodulator-free benefits in autoimmune diseases.

Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...

Market News
Bullish
5 hours ago
Vitalik Buterin says Ethereum's fee-burning model was never a strong investment base for ETH value.

Vitalik Buterin says Ethereum's fee-burning model was never a strong investment base for ETH value.

Ethereum co-founder Vitalik Buterin challenged the idea that Ethereum's transaction fee-burning mechanism under EIP-1559 reliably supports ETH's valuation. He argued that ETH's value should focus more on its role as a store of value and the network's...

Protocol Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App